CUBE vs KYMR · P/E 25, rev $1.07B vs rev $47.1M
CubeSmart (CUBE) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported KYMR revenue for 2024-12-31 was $47.1M. Net income was -$223.9M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. KYMR currently screens at market cap $7.39B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the CUBE and KYMR stock pages for the full models.
Not investment advice.